|
Double Attack
A new kind of high-throughput screening may truly make drugs better, faster, cheaper.
Although physicians and pharmaceutical scientists often combine drugs when a benefit is predictable, until now, scientists had no reliable means of testing possible combinations�nor, indeed, any compelling reason to do so. In June, however, researchers at CombinatoRx published a paper in the Proceedings of the National Academy of Sciences demonstrating not only how drug combinations can be tested systematically, but also that some may have surprisingly therapeutic benefits.1
 |
|
News Analysis
Ready or Not
Vive la Differentiation!
Shrinking Staffs
» Double Attack
Bull�s-Eye?
Biotech Buys
Sniffing for SNPs
1 Borisy, A.A., et al. (2003) Systematic discovery of multicomponent therapeutics. Proceedings of the National Academy of Sciences U.S.A. 100:7977�82.
|
